Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor

Cell Mol Immunol. 2020 Jun;17(6):647-649. doi: 10.1038/s41423-020-0426-7. Epub 2020 Apr 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / immunology*
  • Cloning, Molecular
  • HEK293 Cells
  • Humans
  • Protein Binding
  • Receptor, Angiotensin, Type 2 / immunology*
  • Spike Glycoprotein, Coronavirus / immunology*

Substances

  • AGTR2 protein, human
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Receptor, Angiotensin, Type 2
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2